Ticker AVCO – Avalon Globocare – sales, description, marketcap – Tickerday.com

AVCO

Avalon Globocare

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 117.70M; Volume: 3.58M; AvgVol 3m: 873.74K; Beta: 0.55;

Cost estimate:

P/E: ; EPS: -0.20; EPS growth quarter/prev quarter: 33.10%;

EPS growth this year: -122.80%; EPS growth past 5 years: ;

EPS ttm: -0.20;

P/S: 64.02; P/B: 19.17; P/Cashflow: 80.02; P/FCF: ;

Sales: 1.46M; Sales growth quarter/prev quarter: -25.00%; Sales growth past 5 years: ;

Profitability:

Gross Margin: 22.00%; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -148.00%; ROE – return on equity: -309.90%; LT Debt/Equity: 0.70; Total Debt/Equity: 0.00;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 32.40%; Insider Transactions:0.00%;

Institutional Ownership: 3.40%; Institutional Transactions: -3.80%;

Data update: 07/10/2020.

Leave a comment

Your email address will not be published. Required fields are marked *